QR code

First‐In‐Human Safety, Pharmacokinetics, and Pharmacodynamics of VENT‐02 Freebase, a CNS‐Penetrant NLRP3 Inhibitor

ABSTRACT The NLRP3 inflammasome is a central mediator of innate immunity and a key driver of inflammatory and neurodegenerative diseases. VENT‐02 is orally bioavailable, central nervous system‐penetrant, selective small‐molecule inhibitor of NLRP3. This first‐in‐human, randomized, double‐blind, plac...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Lisanne C. A. Smidt, Matthijs Moerland, Manon A. A. Jansen, Philip H. C. Kremer, Alexandra A. J. Sille, Pamela K. Strugala, Erica S. Klaassen, Anick Auger, Silvana Jananji, Rania Faidi, Kelly A. Pike, Loraine Warner, Andre Matta, Xavier Valencia, Ofer Spiegelstein
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Wiley 2026-05-01
Reeks:Clinical and Translational Science
Online toegang:https://doi.org/10.1111/cts.70578
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items